JPWO2021044436A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021044436A5
JPWO2021044436A5 JP2022514468A JP2022514468A JPWO2021044436A5 JP WO2021044436 A5 JPWO2021044436 A5 JP WO2021044436A5 JP 2022514468 A JP2022514468 A JP 2022514468A JP 2022514468 A JP2022514468 A JP 2022514468A JP WO2021044436 A5 JPWO2021044436 A5 JP WO2021044436A5
Authority
JP
Japan
Prior art keywords
antigen
carrier protein
sugar
protein conjugate
salmonella enterica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022514468A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022546763A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2020/050763 external-priority patent/WO2021044436A2/en
Publication of JP2022546763A publication Critical patent/JP2022546763A/ja
Publication of JPWO2021044436A5 publication Critical patent/JPWO2021044436A5/ja
Pending legal-status Critical Current

Links

JP2022514468A 2019-09-03 2020-09-02 腸疾患に対する免疫原性組成物およびその調製のための方法 Pending JP2022546763A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201921035435 2019-09-03
IN201921035435 2019-09-03
PCT/IN2020/050763 WO2021044436A2 (en) 2019-09-03 2020-09-02 Immunogenic compositions against enteric diseases and methods for its preparation thereof

Publications (2)

Publication Number Publication Date
JP2022546763A JP2022546763A (ja) 2022-11-08
JPWO2021044436A5 true JPWO2021044436A5 (es) 2023-08-01

Family

ID=72659843

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022514468A Pending JP2022546763A (ja) 2019-09-03 2020-09-02 腸疾患に対する免疫原性組成物およびその調製のための方法

Country Status (20)

Country Link
US (1) US20230149524A1 (es)
EP (2) EP4249061A3 (es)
JP (1) JP2022546763A (es)
KR (1) KR20220087437A (es)
CN (1) CN114728053A (es)
AR (1) AR119884A1 (es)
AU (1) AU2020343943A1 (es)
BR (1) BR112022003892A2 (es)
CA (1) CA3149972A1 (es)
CO (1) CO2022003789A2 (es)
CR (1) CR20220132A (es)
EC (1) ECSP22031077A (es)
GB (1) GB2603362A (es)
IL (1) IL291006A (es)
JO (1) JOP20200214A1 (es)
MA (1) MA56283A1 (es)
MX (1) MX2022002693A (es)
PE (1) PE20221442A1 (es)
WO (1) WO2021044436A2 (es)
ZA (1) ZA202203368B (es)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4459286A (en) 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
WO1998026799A1 (en) * 1996-12-18 1998-06-25 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Conjugate vaccine for salmonella paratyphi a
JP2004505885A (ja) 1998-08-19 2004-02-26 ノース　アメリカン　ワクチン，　インコーポレイテッド Ｎ−アクリロイル化ポリサッカリドを用いて産生されたワクチンとして有用な免疫原性β−プロピオンアミド連結ポリサッカリド−タンパク質結合体
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
US9931397B2 (en) 2005-06-27 2018-04-03 Glaxosmithkline Biologicals S.A. Immunogenic composition
KR20090074040A (ko) 2006-09-13 2009-07-03 아보트 러보러터리즈 세포 배양의 개선
GB0700135D0 (en) * 2007-01-04 2007-02-14 Glaxosmithkline Biolog Sa Vaccine
FR2938265B1 (fr) 2008-11-12 2011-07-15 Univ Claude Bernard Lyon Procede pour le pilotage d'un traitement de depolymerisation par ultrasons d'un biopolymere hydrosoluble
BR112012014882B1 (pt) * 2009-12-17 2022-05-31 Fina Biosolutions, Llc Processo de conjugação de carboidratos na preparação de vacinas conjugadas e suas respectivas vacinas ou agentes diagnósticos
US9011871B2 (en) * 2011-11-07 2015-04-21 University Of Maryland, Baltimore Broad spectrum vaccine against typhoidal and non-typhoidal Salmonella disease
US9283270B2 (en) * 2012-01-20 2016-03-15 Serum Institute Of India Ltd. Method for stabilization of biological molecules
MX354103B (es) 2012-01-30 2018-02-13 Serum Inst India Ltd Composicion inmunogenica.
CN102935226B (zh) * 2012-11-16 2014-01-22 罗益（无锡）生物制药有限公司 伤寒甲型副伤寒结合疫苗及其制备方法
WO2015029056A1 (en) * 2013-08-24 2015-03-05 Bharat Biotech International Limited A bacterial vaccine and methods for manufacture thereof
EA039487B1 (ru) * 2015-07-04 2022-02-01 Бхарат Байотек Интернэшнл Лимитед Комбинированные полисахаридные вакцинные композиции и способ получения бактериальных капсульных полисахаридов
EA201900117A1 (ru) 2016-08-26 2019-09-30 Серум Инститьют Оф Индиа Прайвит Лимитид Комбинированная вакцина и способ её производства (варианты)
BR112019022868A2 (pt) * 2017-05-05 2020-05-19 Serum Institute Of India Private Limited método para remoção de impurezas de preparações à base de polissacarídeo capsular bacteriano
EP3655024A1 (en) 2017-07-18 2020-05-27 Serum Institute of India Private Limited An immunogenic composition having improved stability, enhanced immunogenicity and reduced reactogenicity and process for preparation thereof
JOP20190242A1 (ar) 2018-10-12 2020-04-12 Serum Institute Of India Pvt Ltd تركيبة لقاح توليفي تشمل فيروس شلل الأطفال ذو جرعة مخفّضة خاملة التنشيط وطريقة لتحضيرها

Similar Documents

Publication Publication Date Title
DK2815762T3 (en) Process for Conjugation of Bacterial Polysaccharides to Carrier Proteins
JP7275277B2 (ja) ストレプトコッカス・ニューモニエ多糖－タンパク質コンジュゲートを含む組成物およびその使用方法
EP2683408B1 (en) Process for conjugation of bacterial antigen to a carrier protein
JPWO2021044436A5 (es)
GB2603362A (en) Immunogenic compositions against enteric diseases and methods for its preparation thereof
US12016914B2 (en) Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
OA20613A (en) Immunogenic compositions against enteric diseases and methods for its preparation thereof.
AU2012101554B4 (en) Conjugation process of bacterial polysaccharides to carrier proteins